Americans look to Canada for lower drug prices, but are they getting the full picture?: Nigel Rawson and John Adams in The Hill
This article originally appeared in The Hill. The full article can be read here. By Nigel Rawson and John Adams, ...
Tag: Health Policy
The unbalanced state of Canadian healthcare regulation: David Zitner for Inside Policy
By David Zitner, September 18, 2023 When it comes to healthcare regulation in Canada, there are glaring disparities that have ...
Waiting for new drugs for rare disorders in Canada
By Nigel Rawson and John Adams September 6, 2023 PDF of commentary This commentary was originally published as a series ...
Waiting for new drugs for rare disorders in Canada, part 6 – national pharmacare: Nigel Rawson and John Adams for Inside Policy
This article is the sixth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada, part 5 – Patented Medicine Prices Review Board: Nigel Rawson and John Adams for Inside Policy
This article is the fifth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada, part 4 – government drug plan listing: Nigel Rawson and John Adams for Inside Policy
This article is the fourth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy
This article is the second part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Waiting for new drugs for rare disorders in Canada – part 1, regulatory approval: Nigel Rawson and John Adams for Inside Policy
This article is the first in an 8-part series from the authors. The series, Waiting for new drugs for ...
Court support for drug price controls will hurt health care: Richard C. Owens in the Financial Post
This article originally appeared in the Financial Post. Below is an excerpt from the article, which can be read in ...
National drug plan process doesn’t add up: Nigel Rawson in the Hamilton Spectator
This article originally appeared in the Hamilton Spectator. By Nigel Rawson, February 23, 2022 Theatre of the Absurd features plays ...
The Mazankowski report, 20 Years Later
As Canada grapples with an increasingly unsustainable health care system, the Mazankowski report’s bold proposals continue to resonate 20 years ...
It’s Time To End Vaccine Mandates: Dr. Matthew Strauss for Inside Policy
We cannot make perfect the enemy of the good. This country is built on compromise. And in a liberal democracy, ...
Top News
-
Breaking barriers: How provinces can drive Canada’s prosperity by unlocking trade and labour mobility
-
Canada’s hidden crisis – How fentanyl fuels a deadly cross-border drug trade: Sean Parker, Abdelaziz Abouelhoda, May Serageldin, and Sheeraz Ullah for Inside Policy
-
Swimming against the tide: The case for salmon fish farming in British Columbia
-
Canada’s greenwashing amendment: A failure of process and policy
-
As the U.S. abandons DEI, Canada doubles down: Dave Snow in The Hub
